Clinically reviewed by Dr. Sarah Boss, MD
New or severe chest pain, fainting or serious breathing difficulty should not be assumed to be panic. Seek urgent assessment for severe symptoms or suicidal danger. Do not abruptly stop regular benzodiazepines or use extra sedatives to manage an unexplained episode.
Panic disorder can make ordinary activities feel unpredictable or unsafe. Medication may reduce recurrent attacks and the anxiety surrounding them, but the purpose is not simply to sedate every frightening sensation. A good plan distinguishes a panic attack from panic disorder, checks other explanations for physical symptoms and combines treatment with practical and psychological support. Antidepressants have a central role in longer-term medication treatment; rapid relief and sustained recovery are different questions.
A panic attack is not the same as panic disorder
A panic attack is an episode of intense fear or discomfort with physical symptoms. Panic disorder involves recurrent unexpected attacks and persistent worry or behavioral changes related to further attacks. Not everyone who experiences one attack has the disorder. Assessment should consider the pattern, duration, avoidance and impact on everyday life rather than diagnosing from a single symptom list. [1]
New chest pain, collapse, severe breathlessness or unfamiliar neurological symptoms should not be assumed to be panic, even in someone with a previous diagnosis. A clinician may need to exclude a physical cause, a medication effect or substance-related illness. Once a pattern has been assessed, ask for a plan describing what to do during familiar episodes and what changes require urgent help.
What a treatment assessment should cover
Describe how episodes begin, their frequency, the situations you avoid and the changes made to prevent another attack. Include sleep, caffeine, alcohol, cannabis, stimulants, prescribed medicines and missed doses. A brief timeline may reveal links worth investigating without proving that any one factor is the cause.
Discuss depression, trauma symptoms, social anxiety, agoraphobia and other co-occurring difficulties. These can influence the choice of treatment and what should be addressed first. The goal is a coherent explanation of the current problems, not several unrelated prescriptions for every symptom. A panic-disorder label should not obscure a new mood episode or a separate medical concern.
CBT and medication address different parts of the problem
Cognitive behavioral therapy for panic disorder works on the interpretation of bodily sensations, fear of further attacks and avoidance. It may include carefully planned exposure to feared situations or sensations. Medication can reduce symptoms, but it does not automatically change all the beliefs or behaviors that have developed around panic. [1]
Ask whether the therapy offered specifically addresses panic rather than only providing general reassurance. A treatment plan may use therapy, medicine or both, according to severity, preferences and previous response. The important outcome is renewed ability to participate in life, not merely a lower symptom score while avoidance continues unchanged.
SSRIs and SNRIs in longer-term treatment
NICE recommends an antidepressant licensed for panic disorder when medication is chosen. Its guidance lists SSRIs such as sertraline, escitalopram, citalopram and paroxetine, and the SNRI venlafaxine among licensed options in the UK context. Authorization can differ by country and formulation; fluoxetine, for example, has panic-disorder use in other prescribing systems. [2]
The profiles for sertraline, paroxetine and venlafaxine explain individual precautions. An antidepressant prescription does not mean panic has been mistaken for depression. These medicines have uses beyond depression, but the prescriber should still state the diagnosis and intended benefit clearly.
Why an antidepressant is not a rescue tablet
Antidepressants are generally taken consistently and assessed over time. They do not act as a reliable immediate way to stop an attack after it begins. Early treatment may also temporarily increase anxiety or disturb sleep. That possibility should be explained with a monitoring plan, rather than leaving a person to interpret every early sensation as evidence that treatment is dangerous or ineffective.
Ask when the team expects to assess early tolerability and later benefit. Record attacks, anticipatory worry and avoided activities in a manageable way. Persistent or severe effects need review, and marked agitation or suicidal thoughts require prompt contact. Do not take extra tablets during an attack or change the schedule because one day feels more difficult. [3]
When a tricyclic antidepressant is discussed
If an SSRI is unsuitable or has not helped adequately, a clinician may discuss another approach, including clomipramine or imipramine in relevant circumstances. NICE identifies these panic-disorder uses as off-label. This is not a reason to use leftover medication or assume all tricyclics have the same evidence. The purpose and regulatory position should be explained. [3]
Tricyclics have additional concerns, including anticholinergic effects, sedation, heart effects and greater toxicity in overdose. The clomipramine guide describes its individual precautions. Physical-health history, suicide risk, other medicines and the feasibility of monitoring are important parts of the decision, not administrative details after a drug is chosen.
Benzodiazepines: licensing and guideline advice differ
Some benzodiazepines, including particular alprazolam and clonazepam products, have panic-related indications in certain countries. They can reduce anxiety rapidly, but tolerance, dependence, sedation and withdrawal create important limitations. Their availability or approval does not mean they are the preferred continuing treatment for every person with panic disorder.
NICE advises against prescribing benzodiazepines for panic disorder and against sedating antihistamines or antipsychotics as panic treatment. US patient guidance describes selected brief benzodiazepine use while emphasizing dependence concerns. The differing context should be acknowledged rather than turning either statement into a universal rule. A person already taking a benzodiazepine regularly should arrange review, not stop suddenly. [2] [1]
Beta blockers and the limits of treating physical symptoms
A beta blocker may reduce certain physical signs of anxiety in selected circumstances, but that is not equivalent to treating the full cycle of recurrent panic and avoidance. It is not a universal substitute for CBT or antidepressant treatment. NIMH notes that beta blockers are not commonly prescribed for panic disorder. The clinician should explain any specific reason for using one.
Do not borrow propranolol to test whether a racing heart is anxiety. It has its own contraindications and can affect blood pressure, pulse and breathing in susceptible people. An unexplained symptom needs assessment rather than being masked with a medicine chosen from a comparison page.
Side effects and interactions to discuss
Antidepressants may cause nausea, headache, sleep changes, sweating or sexual difficulties. Different drugs have different blood-pressure, heart-rhythm and interaction concerns. Review prescriptions, supplements, pain medicines and occasional cold or sleep remedies together. MAO inhibitors and some serotonergic combinations require particular care. The pharmacist needs the full list, not only medicines considered psychiatric.
Tell the team about pregnancy plans, breastfeeding, epilepsy, heart disease or liver and kidney problems. These circumstances require individual assessment. Severe allergy, a seizure, collapse or fever with confusion and marked muscle stiffness needs urgent medical care. A previously diagnosed anxiety disorder is not an explanation for every new symptom.
Alcohol, stimulants and other substance use
Alcohol may be used to cope with anticipatory anxiety, while stimulants, heavy caffeine use or withdrawal from sedatives can produce sensations that resemble panic. Discuss the actual pattern without assuming that every attack is caused by substances. Both panic disorder and a substance-use problem may need treatment.
Combining alcohol or opioids with benzodiazepines can be dangerous. Do not increase a sedative dose because an episode feels severe or mix substances to make a prescription feel more calming. Where physical dependence is present, major changes in alcohol or sedative use need clinical advice. The benzodiazepine withdrawal guide explains why a supervised plan matters.
Withdrawal is not automatically a return of panic disorder
Antidepressant withdrawal may cause dizziness, anxiety, disturbed sleep and other symptoms after a missed dose or reduction. Benzodiazepine withdrawal can also produce marked anxiety and may be medically dangerous. These possibilities need to be considered alongside recurrence of panic disorder and physical illness, rather than choosing one explanation from the symptoms alone.
Record what changed, the dates, the exact medicine and any other substances. Do not repeatedly stop and restart medication to test the cause. A clinician-led reduction should include follow-up and a plan for difficulties. The withdrawal-or-relapse guide provides a framework for questions, not a self-diagnostic test.
Reviewing response and returning to daily activities
Consider more than the number of attacks. Can you use transport, attend appointments, remain in a meeting or take part in family life more freely? Has anticipatory worry reduced, and are activities being resumed rather than avoided? These changes help distinguish improved functioning from simply arranging life so that feared situations never occur.
If response is incomplete, review the diagnosis, medicine trial, actual use, adverse effects and access to appropriate CBT. A change should have a clear rationale and a way to assess its result. The medication-review checklist can organize the history and help avoid repeating an earlier trial without understanding why it ended.
Planning what to do between appointments
Ask for written instructions about familiar episodes, new warning signs and contact routes. Keep the plan accessible without repeatedly checking it as a way to seek certainty. A supporter can help by understanding the agreed approach and not offering unprescribed medicines. Urgent or unfamiliar symptoms should be assessed on their own merits.
When changing services, transfer the diagnosis, current treatment, previous medication trials and the agreed psychological plan. Continuity matters particularly if a supply interruption or abrupt change could cause withdrawal symptoms that are easily confused with panic. A planned handover is more useful than a list of brand names without the reason each was used.
Frequently asked questions
Does every panic attack need medication?
No. An isolated attack does not establish panic disorder, and treatment depends on assessment, recurrence, impairment and preferences. New serious physical symptoms still require medical attention.
Why might anxiety increase early in treatment?
Some antidepressants can cause early activation or sleep disruption. Discuss the pattern with the prescriber; severe agitation or suicidal thoughts needs prompt assessment rather than routine reassurance.
Can I stop after the attacks improve?
Review continuation and any reduction with the clinician. Improvement, residual avoidance, previous episodes and withdrawal risk all matter. Do not stop suddenly just because a few weeks have been better.
Is a rapid calming effect the best outcome?
Not necessarily. The longer-term goals include fewer attacks, less fear of future attacks and greater participation in daily life, with a tolerable and sustainable treatment plan.
